Date | Time | Source | Announcement |
---|---|---|---|
01 Feb 2006 | 07:00 AM | Additional Listing | |
16 Jan 2006 | 12:28 PM | Additional Listing | |
03 Jan 2006 | 12:50 PM | Holding(s) in Company | |
21 Dec 2005 | 04:14 PM | Additional Listing | |
09 Dec 2005 | 07:00 AM | Re: Global Rights | |
30 Nov 2005 | 10:18 AM | Additional Listing | |
28 Nov 2005 | 07:00 AM | EU Marketing Submission | |
21 Nov 2005 | 07:00 AM | Study Results | |
07 Nov 2005 | 07:00 AM | Study Results | |
05 Sep 2005 | 07:00 AM | Interim Results | |
12 Aug 2005 | 07:00 AM | Product development update | |
19 Jul 2005 | 11:00 AM | Notice of Results | |
06 Jul 2005 | 07:00 AM | SSL acquires rights to FLD500 | |
05 Jul 2005 | 10:45 AM | Holding(s) in Company | |
06 Jun 2005 | 03:38 PM | Notice of AGM | |
17 May 2005 | 02:44 PM | Holding(s) in Company | |
25 Apr 2005 | 07:00 AM | Manufacturing trials | |
22 Mar 2005 | 10:11 AM | Grant of options | |
21 Mar 2005 | 07:00 AM | Final Results | |
18 Mar 2005 | 12:58 PM | Notice of Results | |
28 Feb 2005 | 01:06 PM | Change of Advisers | |
01 Feb 2005 | 04:00 PM | Holding(s) in Company | |
02 Dec 2004 | 03:01 PM | Holding(s) in Company | |
15 Nov 2004 | 07:01 AM | Additional Listing | |
15 Nov 2004 | 07:00 AM | Research Update | |
27 Sep 2004 | 07:00 AM | Interim Results | |
21 Sep 2004 | 12:46 PM | Notice of Results-Correction | |
21 Sep 2004 | 08:00 AM | Appointment of joint broker | |
20 Sep 2004 | 07:00 AM | Notice of Results | |
24 Aug 2004 | 02:03 PM | Holding in Company | |
21 Jul 2004 | 02:39 PM | Additional Listing | |
21 Jul 2004 | 10:19 AM | Additional Listing | |
12 Jul 2004 | 07:00 AM | Reformulation of treatment | |
01 Jul 2004 | 05:55 PM | Sale of royalty rights | |
15 Jun 2004 | 11:29 AM | Holding in Company | |
26 May 2004 | 07:00 AM | Results of clinical trial | |
21 Apr 2004 | 07:00 AM | Non-exercise of option | |
21 Apr 2004 | 07:00 AM | Result of pilot med. trial | |
15 Apr 2004 | 12:07 PM | Holding in Company | |
05 Apr 2004 | 11:40 AM | Holding in Company | |
08 Mar 2004 | 07:00 AM | Issue of Equity | |
23 Feb 2004 | 03:40 PM | Additional Listing | |
23 Feb 2004 | 11:53 AM | Final Results-Replacement | |
23 Feb 2004 | 07:00 AM | Progress in concept study | |
23 Feb 2004 | 07:00 AM | Final Results | |
20 Feb 2004 | 12:11 PM | Holding(s) in Company | |
18 Feb 2004 | 10:28 AM | Holding(s) in Company | |
17 Feb 2004 | 11:04 AM | Additional Listing | |
16 Feb 2004 | 03:49 PM | Additional Listing | |
13 Feb 2004 | 05:07 PM | Holding(s) in Company |
Futura Medical is the developer of innovative sexual health products, including lead product Eroxon®. Our core strength lies in our research, development and commercialisation of topically delivered gel formulations in sexual health products.
FUM share price listed on AIM in 2003.